600
Participants
Start Date
March 4, 2025
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2027
Natera® Empower™ hereditary cancer panel test
The test will be the Natera® Empower™ hereditary cancer panel test and will be collected by saliva.
Specialist Referral
Participants with actionable pathogenic variants will be referred to the appropriate specialists (e.g., medical oncologist, gynecologic oncologist, breast surgeon) to discuss risk-reduction strategies and offered genetic counseling
RECRUITING
NYU Langone Health, New York
NYU Langone Health
OTHER